Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted
Clinical trial NCT03832114 · COMPLETED
Trial details
- NCT number
- NCT03832114
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2021-04-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.